Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen Pan

Showing results (601-610 of 627) with videos related to

Pageof 63
Sort By:
International Journal of Surgery (London, England)|August 7, 2024
A machine learning model utilizing Delphian lymph node characteristics to predict contralateral central lymph node metastasis in papillary thyroid carcinoma: a prospective multicenter studyJia-Ling He, Yu-Zhao Yan, Yan Zhang, et al.
Journal for Immunotherapy of Cancer|October 4, 2024
PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF-caspase 8-GSDMD/E axis in ovarian cancerYu Xia, Pu Huang, Yi-Yu Qian, et al.
Science Translational Medicine|May 7, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacyJiahao Liu, Xiaofei Jiao, Wei Mu, et al.
Immunity|August 17, 2017
The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma ProgressionWen Pan, Shu Zhu, Kun Qu, et al.
Science Bulletin|April 7, 2023
Nanonitrator: novel enhancer of inorganic nitrate's protective effects, predicated on swarm learning approachWen Pan, Geng Hu, Shaorong Li, et al.
Cell Reports. Medicine|April 21, 2026
Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trialYang Liu, Xin-Yue Zhang, Wen-Su Wei, et al.
Science Translational Medicine|May 27, 2026
Genomic instability drives POSTN<sup>+</sup> myofibroblasts via STING-WNT axis to promote immunosuppression and PARPi resistance in ovarian cancerDan Liu, Kangjia Tao, Chujun Cai, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 5, 2025
ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancerShen-Nan Shi, Qiuyang Xu, Zhiqi Liao, et al.
Brain Imaging and Behavior|September 9, 2021
Spindle-related brain activation in patients with insomnia disorder: An EEG-fMRI studyYan Shao, Guangyuan Zou, Serik Tabarak, et al.
The Journal of Clinical Investigation|February 24, 2026
Tumor cell-derived IFN spatially reprograms osteopontin-enriched macrophage niches to promote PARP inhibitor resistanceDan Liu, Kangjia Tao, Cheng Xu, et al.
Pageof 63

Showing results (601-610 of 627) with videos related to

Sort By:
Pageof 63
International Journal of Surgery (London, England)|August 7, 2024
A machine learning model utilizing Delphian lymph node characteristics to predict contralateral central lymph node metastasis in papillary thyroid carcinoma: a prospective multicenter studyJia-Ling He, Yu-Zhao Yan, Yan Zhang, et al.
Journal for Immunotherapy of Cancer|October 4, 2024
PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF-caspase 8-GSDMD/E axis in ovarian cancerYu Xia, Pu Huang, Yi-Yu Qian, et al.
Science Translational Medicine|May 7, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacyJiahao Liu, Xiaofei Jiao, Wei Mu, et al.
Immunity|August 17, 2017
The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma ProgressionWen Pan, Shu Zhu, Kun Qu, et al.
Science Bulletin|April 7, 2023
Nanonitrator: novel enhancer of inorganic nitrate's protective effects, predicated on swarm learning approachWen Pan, Geng Hu, Shaorong Li, et al.
Cell Reports. Medicine|April 21, 2026
Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trialYang Liu, Xin-Yue Zhang, Wen-Su Wei, et al.
Science Translational Medicine|May 27, 2026
Genomic instability drives POSTN<sup>+</sup> myofibroblasts via STING-WNT axis to promote immunosuppression and PARPi resistance in ovarian cancerDan Liu, Kangjia Tao, Chujun Cai, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 5, 2025
ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancerShen-Nan Shi, Qiuyang Xu, Zhiqi Liao, et al.
Brain Imaging and Behavior|September 9, 2021
Spindle-related brain activation in patients with insomnia disorder: An EEG-fMRI studyYan Shao, Guangyuan Zou, Serik Tabarak, et al.
The Journal of Clinical Investigation|February 24, 2026
Tumor cell-derived IFN spatially reprograms osteopontin-enriched macrophage niches to promote PARP inhibitor resistanceDan Liu, Kangjia Tao, Cheng Xu, et al.
Pageof 63